COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab

COVID-19 Vaccine Failure in a Patient with Multiple Sclerosis on Ocrelizumab

Vaccines will play a key role in ending the COVID-19 pandemic. Vaccination against infections remains an important part of the management of patients with multiple sclerosis. However, there are limited data about the safety and efficacy of the currently available COVID-19 mRNA vaccines in patients w...

Full description

Bibliographic Details
Main Authors: Sridhar Chilimuri, Nikhitha Mantri, Sudharsan Gongati, Maleeha Zahid, Haozhe Sun
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
COVID-19
vaccination
B-Cell
ocrelizumab
multiple sclerosis
humoral immunity
Online Access:https://www.mdpi.com/2076-393X/9/3/219

Internet

https://www.mdpi.com/2076-393X/9/3/219

Similar Items